H.C. Wainwright & Co., LLC ("HCW") announces a significant milestone, securing its #1 ranking for the 40th consecutive quarter in PlacementTracker’s Market League Tables by transaction volume. "This ...

Stock analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a research note issued on Wednesday, March 26th. HC Wainwright analyst E. White now ...

H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the FDA regarding its new drug application for its ...

Alberta is flexing its muscle, putting in a strong showing as Canada’s national housing awards released its finalist list for ...

It's do or die for the Lloydminster Bandits as they find themselves down 3-2 in a championship series with the Wainwright ...

Five colleges, including Lakeland have signed an agreement which will expand education across northern Alberta. The ...

The commission to lead electoral map change-ups got a kick start with this week’s appointment of Lethbridge King’s Court ...

Nektar Therapeutics today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual ...

Jeff Edward Medd, 41, of Leduc County, was sentenced to 910 days behind bars in Wetaskiwn Court of Justice on March 13, 2025.

Check out the best moments from Game 1 of the Tokyo Series between the Los Angeles Dodgers and the Chicago Cubs.

HC Wainwright analyst A. Maldonado now anticipates that the biopharmaceutical company will post earnings of ($0.98) per share for the quarter, up from their previous forecast of ($1.33).